CJ, VaxInnate to join forces in flu vaccine production

Published: 2011-12-21 06:56:00

Updated: 2011-12-21 06:56:00

CJ CheilJedang Corp. announced Monday that it has signed an exclusive licensing agreement with the U.S. based VaxInnate Corporation, a privately-held biotechnology company, granting a license to CJ to manufacture, develop and commercialize VaxInnate’s recombinant seasonal and pandemic flu vaccine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK